Compare PLAG & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLAG | PLUR |
|---|---|---|
| Founded | 1986 | 2001 |
| Country | United States | Israel |
| Employees | 6 | N/A |
| Industry | Packaged Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.6M | 28.4M |
| IPO Year | 2007 | 2001 |
| Metric | PLAG | PLUR |
|---|---|---|
| Price | $2.45 | $3.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 264.5K | 11.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.56 | 10.78 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $6,729,937.00 | $1,336,000.00 |
| Revenue This Year | N/A | $97.38 |
| Revenue Next Year | N/A | $293.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 309.82 |
| 52 Week Low | $0.47 | $2.82 |
| 52 Week High | $4.49 | $7.13 |
| Indicator | PLAG | PLUR |
|---|---|---|
| Relative Strength Index (RSI) | 44.01 | 57.06 |
| Support Level | $1.56 | $3.43 |
| Resistance Level | $3.07 | $3.85 |
| Average True Range (ATR) | 0.55 | 0.26 |
| MACD | -0.16 | -0.00 |
| Stochastic Oscillator | 17.03 | 68.92 |
Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.